Don't Even Think About Regencell Stock Until You See Flag
Regencell Bioscience sits in the high-risk, high-reward world of early-stage biotech. Before you consider investing, ...
Index level declines can reflect profit-taking, macro shocks, or sector rotations. This intro covers common indicators to read with context.
23,215 articlesRegencell Bioscience sits in the high-risk, high-reward world of early-stage biotech. Before you consider investing, ...
The IRS is proposing electronic delivery of Form 1099-DA for digital asset trades, with exchanges potentially termina...
Disney faces a cash flow decline even as streaming profitability edges higher. The market-wide tug-of-war keeps DIS a...
A major cold storage leader caught the eye of a notable investor, who disclosed a fresh stake worth $19 million. This...
Conagra Brands is pouring $220 million into a key manufacturing upgrade, signaling confidence in demand. But does tha...
CrossCountry Mortgage will acquire Summit Funding, a move that broadens its geographic reach and scales its lending p...
ZIM shares hover near $27.54, well under Hapag-Lloyd’s $35 cash proposal. The discount reflects regulatory risk aroun...
Strategy widens its ATM funding to over $60B to buy BTC, signaling bigger bets on the digital asset. The move could l...
Investors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
Andreessen Horowitz's crypto unit closes its fifth fund at $2.2 billion, signaling a patient, long-horizon bet on cry...
Looking ahead at geron (gern) 2026 earnings, this guide breaks down the catalysts, cash runway, and risks shaping the...
A standout quarterly report helped Rhythm Pharmaceuticals stock surge on Tuesday as investors embraced better-than-ex...